Prevalence and clinical features of chronic uveitis in pediatric inflammatory bowel diseases: A nationwide study

Valerio Maniscalco1, Luca Scarallo2,3, Marina Aloi4

  • 1Rheumatology Unit, ERN-ReCONNET Center, Meyer Children Hospital IRCCS, Florence, Italy.

Insights

Uveitis, an eye condition, is a rare complication in pediatric Inflammatory Bowel Disease (IBD). This study found a low prevalence of uveitis in children with IBD, with most cases showing inactive disease and IBD at follow-up.

Area of Science:

  • Ophthalmology
  • Gastroenterology
  • Pediatrics

Background:

  • Inflammatory Bowel Disease (IBD) comprises chronic gastrointestinal inflammatory disorders.
  • Ocular manifestations, particularly uveitis, can occur in IBD patients.
  • Pediatric IBD presents unique challenges in managing extra-intestinal complications.

Purpose of the Study:

  • To determine the prevalence of uveitis in a nationwide cohort of pediatric Inflammatory Bowel Disease patients.
  • To describe the clinical features and outcomes of uveitis in this population.
  • To assess the relationship between IBD activity and ocular involvement.

Main Methods:

  • Retrospective analysis of a nationwide cohort of pediatric IBD patients.
  • Identification of patients diagnosed with uveitis.
  • Review of medical records for clinical characteristics, IBD type, uveitis onset, and follow-up data.

Main Results:

  • Six cases of uveitis were identified among 4229 pediatric IBD patients, yielding a prevalence of 141.8 per 100,000.
  • Uveitis onset occurred before, after, or concurrently with IBD diagnosis.
  • All identified uveitis cases involved anterior segment inflammation; 2/6 were symptomatic. At follow-up, most patients had quiescent IBD and inactive uveitis, though one experienced ocular complications.

Conclusions:

  • Uveitis is an uncommon but significant ocular complication in pediatric Inflammatory Bowel Disease.
  • Early recognition and management are crucial for favorable outcomes.
  • Further research is warranted to elucidate the pathogenesis and optimize treatment strategies.

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
449
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
227
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
173
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
159
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127